AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
AMED
Shares outstanding
32,982,385
Price per share
$99.80
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
542
Total reported value
$61,595
% of total 13F portfolios
0%
Share change
-32,982,247
Value change
-$3,244,432,642
Number of holders
4
Price from insider filings
$99.80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GOLDMAN SACHS GROUP INC 0% -108% $19,188 -$178,680,496 190 -100% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025

As of 30 Sep 2025, 4 institutional investors reported holding 542 shares of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED). This represents 0% of the company’s total 32,982,385 outstanding shares.

Institutional Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 542 $61,595 -$3,244,432,642 $99.80 4
2025 Q2 32,988,261 $3,245,032,619 +$158,439,822 $98.39 318
2025 Q1 28,809,873 $2,668,779,642 -$40,704,627 $92.63 298
2024 Q4 29,132,546 $2,644,372,010 +$16,484,940 $90.79 285
2024 Q3 27,980,090 $2,700,311,065 -$153,780,981 $96.51 279
2024 Q2 29,530,723 $2,712,602,319 +$42,645,305 $91.80 281
2024 Q1 29,203,193 $2,691,299,749 -$146,433,859 $92.16 282
2023 Q4 745,507 $70,867,895 +$44,934,577 $95.06 5
2023 Q3 28,992,595 $2,708,219,715 -$77,817,200 $93.40 277
2023 Q2 29,757,719 $2,720,186,349 -$86,785,676 $91.44 291
2023 Q1 31,245,294 $2,298,581,011 +$6,540,766 $73.55 272
2022 Q4 30,482,519 $2,546,985,746 -$50,164,540 $83.54 264
2022 Q3 27,097,871 $2,622,937,077 +$117,029,914 $96.79 256
2022 Q2 25,070,015 $2,638,952,597 -$55,980,183 $105.12 263
2022 Q1 29,838,334 $5,138,324,154 +$163,824,716 $172.29 310
2021 Q4 29,202,811 $4,724,962,552 +$73,947,498 $161.88 308
2021 Q3 28,283,225 $4,217,727,543 -$207,951,960 $149.10 342
2021 Q2 28,937,221 $7,087,071,995 +$85,144,559 $244.93 362
2021 Q1 28,493,803 $7,546,609,680 -$67,715,260 $264.79 382
2020 Q4 29,095,842 $8,533,700,905 +$83,752,272 $293.33 390
2020 Q3 28,488,656 $6,728,219,359 -$177,331,062 $236.43 378
2020 Q2 29,254,663 $5,808,187,293 +$151,785,080 $198.54 339
2020 Q1 28,496,240 $5,227,297,827 -$2,945,769 $183.54 317
2019 Q4 28,988,088 $4,839,143,903 -$101,625,735 $166.92 318
2019 Q3 29,776,072 $3,900,626,871 +$121,675,863 $131.01 277
2019 Q2 28,985,996 $3,514,088,062 +$211,473,485 $121.41 279
2019 Q1 27,960,323 $3,444,975,878 -$139,121,071 $123.26 310
2018 Q4 24,372,068 $2,854,505,918 -$104,964,330 $117.11 292
2018 Q3 29,977,124 $3,744,866,812 -$36,247,945 $124.96 261
2018 Q2 30,474,674 $2,604,636,994 -$128,850,724 $85.46 211
2018 Q1 32,611,799 $1,967,465,792 +$25,087,759 $60.34 190
2017 Q4 32,746,590 $1,726,089,691 +$22,298,214 $52.71 181
2017 Q3 32,445,263 $1,815,139,134 -$51,654,263 $55.96 160
2017 Q2 32,967,339 $2,070,422,751 -$8,485,703 $62.81 168
2017 Q1 32,377,410 $1,654,246,518 +$285,015,307 $51.09 149
2016 Q4 32,444,362 $1,383,153,167 +$33,597,797 $42.63 155
2016 Q3 31,684,214 $1,502,497,074 +$69,119,438 $47.44 152
2016 Q2 30,987,285 $1,564,195,191 +$28,358,274 $50.48 164
2016 Q1 29,315,759 $1,417,039,487 +$18,837,152 $48.34 165
2015 Q4 30,138,967 $1,185,340,410 -$2,245,763 $39.32 162
2015 Q3 30,235,974 $1,148,094,026 +$29,409,594 $37.97 172
2015 Q2 28,728,324 $1,141,372,554 +$46,212,963 $39.73 142
2015 Q1 27,923,708 $748,263,807 -$9,832,709 $26.78 127
2014 Q4 28,726,805 $843,051,239 -$23,203,694 $29.35 138
2014 Q3 29,963,657 $604,380,851 -$6,817,214 $20.17 123
2014 Q2 30,459,722 $510,163,698 +$4,363,519 $16.74 122
2014 Q1 28,835,185 $429,630,208 +$15,132,017 $14.89 115